San Diego-based mostly Viking Therapeutics marked by itself as a significant competitor from the weight loss drug industry in February after revealing promising info from the mid-phase demo of experimental drug VK2735, which advised it rivaled—and outperformed—Novo and Lilly drugs when offered being a weekly injection and in March the company u